Showing results (31-40 of 92) with videos related to
Sort By:
Pageof 10
Journal of Clinical Pharmacology|May 14, 2011
Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veinsChristoph Schindler, Sven Leuschner, Uta Schwanebeck, et al.BMC Public Health|October 25, 2012
Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and FranceWolfgang Boecking, Anna Klamar, Florian Kitzmann, et al.The Annals of Pharmacotherapy|November 4, 2004
First patient-centered drug information service in Germany--a descriptive studyUlf Maywald, Christoph Schindler, Jutta Krappweis, et al.Medizinische Klinik (Munich, Germany : 1983)|February 28, 2006
[Registries for clinical trials -- a critical stock-taking]Kurt Bestehorn, Reinhard Hönig, Norbert Clemens, et al.Medicine 2.0|March 4, 2015
Acceptance factors of mobile apps for diabetes by patients aged 50 or older: a qualitative studyMadlen Scheibe, Julius Reichelt, Maike Bellmann, et al.Current Medical Research and Opinion|April 5, 2007
Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countriesPeter Bramlage, Martin Thoenes, Wilhelm Kirch, et al.Medizinische Klinik (Munich, Germany : 1983)|April 2, 2009
[6-year experience with a drug information service for patients]Martin Huber, Gerd A Kullak-Ublick, Wilhelm KirchInternational Journal of Clinical Pharmacology and Therapeutics|March 1, 2012
Potentially inappropriate prescribing for elderly outpatients in Germany: a retrospective claims data analysisLisa Goltz, Gerd A Kullak-Ublick, Wilhelm KirchPediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 4, 2009
Early exposure to antibiotics and infections and the incidence of atopic eczema: a population-based cohort studyJochen Schmitt, Natalie M Schmitt, Wilhelm Kirch, et al.Vascular Health and Risk Management|June 23, 2007
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapyChristoph Schindler, Peter Bramlage, Wilhelm Kirch, et al.Pageof 10